International Cancer Expert Corps Inc

What it reported doing in 2024

Icec twinning programs/mentoring partnershipscancer care building capacity and capability for low- and middle-income countries (lmic) through mentorship and innovative technology there are low-middle-income countries (lmics) where there is almost no access to cancer care leading to unnecessary deaths and immeasurable suffering. What is needed is access to the appropriate expertise built from the local community and treatment with effective technology to ensure sustainable capacity and capability. The international cancer expert corps is addressing the shortage of cancer care through a two-pronged approach of (1) twinning programs and mentorship to build and sustain expertise and (2) innovative "smart" technology to provide radiation therapy and knowledge-assisted treatment. The icec mentorship corps is being built with international partners in resource-rich high-income countries (hics) with experts serving as mentors with twinning partnerships among champions in lmics. While there is a good measure of volunteerism, financial support is needed for the twinning partners to have the time and basic resources for education, training and ongoing active partnership. In 2021, icec received an endowment bequest from paul kaplan, the son of the world-renowned radiation oncologist henry kaplan and leah kaplan, to support the norman coleman / paul kaplan endowment fund for mentorship. The endowment continues to grow, having received additional contributions in 2024. Initial grants (from the coleman / kaplan fund) were awarded in 2023 and continued throughout 2024. The lack of significant success in addressing the cancer care shortage requires novel, indeed disruptive change with new paradigms. Icec has carefully crafted a novel systems approach to cancer care, as a health systems issue requiring cancer care at the outset rather than a late add-on that often does not happen. The model is called "flex competence" achieving flexible competence: bridging the investment dichotomy between infectious diseases and cancer (british medical journal global health (2020, dec pmid33303514) that addresses communicable diseases (infectious diseases) and non-communicable diseases (cardiac, metabolic, respiratory, oncologic) while enabling local ready-surge capacity for outbreaks and pandemics. Furthermore, addressing the growing issue of an aging global population in need of healthful and purposeful aging, the icec has a pioneering approach "capturing acquired wisdom, enabling healthful aging, and building multinational partnerships through senior global health mentorship" that will bring together world-renowned cancer experts in contact with next generation leaders. It provides a venue for a large range of skilled and determined individuals to "give back and "pay forward" from their life experience and wisdom. Icec's twinning programs and mentoring partnerships bring together cancer care experts from resource-rich settings with healthcare professionals in resource-poor countries to improve cancer prevention, screening, diagnosis, treatment and follow-up care with well-defined governance, established policies and procedures, transparency in operations, and the ability to leverage expertise. Icec partners enhance the ongoing activities of governments, professional societies, cancer centers and other non-governmental organizations. Icec encourages local, regional and national initiatives to develop the sustainable capacity and capability of cancer care personnel in these countries to battle cancer.icec has established twinning programs/mentoring partnerships with goals to, 1) improve, facilitate and sustain population-directed clinical cancer care and translational cancer research at local cancer centers by multi-disciplinary expert mentoring teams, 2) train physicians, nurses, scientists, and other healthcare & health policy workers at these centers in public health oncology, 3) evaluate local cancer care systems and develop model approaches to strengthen

Financial Efficiency

• Mission deployment rate: 19.9%; rating input score 20
• Program expense ratio: 75.2%; rating input score 75
• Fundraising efficiency: $71.21 raised per $1 spent on fundraising; rating input score 83; 83rd percentile among comparable filings

Transparency & Controls

• Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
• Pay-setting controls: Limited
• Foreign activity oversight: 2 of 8 controls in place; rating input score 25
  • Claims monitoring procedures: Pass
  • Requires narrative reports: Limited
  • Conducts field audits: Limited
  • May suspend future funding: Limited
  • Requires financial reports: Limited
  • Conducts site visits: Limited
  • Requires grant agreements: Pass
  • May require repayment: Limited
• Grant itemization coverage: 0%; rating input score 0; 13th percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Limited

Accountability

• Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
• Governance controls: 3 of 8 controls in place; rating input score 38
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Fail
  • Document-retention policy: Fail
  • CEO compensation review process: Fail
  • Other executive compensation review process: NotApplicable
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Fail
  • Independent financial-statement audit: Fail

Sustainability

• Operating margin: 75.2%; rating input score 97; 97th percentile among comparable filings
• Total-asset coverage ratio: 6.14; rating input score 87; 87th percentile among comparable filings
• Liabilities to assets ratio: 0; rating input score 91; 91st percentile among comparable filings
• Officer compensation ratio: 30.2%; rating input score 7; 7th percentile among comparable filings

Growth

• Program expense growth: 59.3% per year; rating input score 100; 97th percentile among comparable filings
• Revenue growth: 35.2% per year; rating input score 100; 94th percentile among comparable filings
• Asset growth: 42.8% per year; rating input score 100; 95th percentile among comparable filings